Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Maurer MJ, Ghesquieres H, Link BK, Jais JP, et al. Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials. J Clin Oncol 2018 Apr 19:JCO2017765198. doi: 10.1200/JCO.2017.76.5198.
PMID: 29672223


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016